Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  134 results for ""Proteinuria urine""

Your Filters

Content Provider : NewsBank
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
News

Travere Therapeutics announces positive topline interim results from the ongoing Phase 3 PROTECT study of sparsentan in IgA nephropathy.

  • Source: Chemical Business NewsBase (UK), August 16, 2021, 3pp

Record details

Read More Add to Saved list
×
News

Ligand partner Travere Therapeutics announces positive topline interim results from the ongoing Phase 3 PROTECT Study of sparsentan in IgA nephropathy.

  • Source: Chemical Business NewsBase (UK), August 16, 2021, 3pp

Record details

Read More Add to Saved list
×
News

Eisai Inc - Lenvatinib Significantly Improved Overall Survival in Older Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer

  • Source: ENP Newswire (UK), August 29, 2017 News, 5pp

Record details

Read More Add to Saved list
×
News

Eisai Inc. - Lenvatinib Delays Deterioration in Certain Domains of Quality of Life in Patients with Unresectable Hepatocellular Carcinoma

  • Source: ENP Newswire (UK), September 12, 2017 News, 5pp

Record details

Read More Add to Saved list
×
News

Eisai Inc. - Combination of Lenvatinib and Pembrolizumab Results in Notable Response Rates for Patients with Advanced Renal Cell Carcinoma

  • Source: ENP Newswire (UK), September 12, 2017 News, 10pp

Record details

Read More Add to Saved list
×
News

Postop AKI Linked to Pre-Surgery Proteinuria

  • Authors : By:Jody A. Charnow, Editor

  • Source: Renal & Urology News (USA), July 5, 2018 News, 2pp

Record details

Read More Add to Saved list
×
News

Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy

  • Source: GlobeNewswire (USA), December 27, 2018, 4pp

Record details

Read More Add to Saved list
×
News

Retrophin Initiates Pivotal Phase 3 Clinical Trial of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis

  • Source: Pharma & Healthcare Monitor Worldwide (Amman, Jordan), April 4, 2018 NEWS, 6pp

Record details

Read More Add to Saved list
×
News

Retrophin Initiates Pivotal Phase 3 Clinical Trial of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis

  • Source: GlobeNewswire (USA), April 3, 2018, 5pp

Record details

Read More Add to Saved list
×
News

CIRCULATING VISFATIN LEVEL AND ITS ASSOCIATION WITH LIPID BIOMARKERS IN PREGNANCY INDUCED HYPERTENSION

  • Authors : By:Asmat Shaheen, Salim Khattak, Zahoor Ahmed, Mussar

  • Source: Gomal Journal of Medical Sciences (Dera Ismail Khan, Pakistan), December 31, 2016 News, 9pp

Record details

Read More Add to Saved list
×
  • 1-10 of  134 results for ""Proteinuria urine""